VICTOZA (liraglutide) – a glucagon-like peptide-1 (GLP-1) receptor agonist commonly used to treat type 2 adult diabetes mellitus. FDA approved uses: Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Available dosage forms: Solution for subcutaneous injection, prefilled multi-dose pen delivering doses of […]
BYETTA (exenatide) – a glucagon-like peptide-1 (GLP-1) receptor agonist commonly used to treat type 2 adult diabetes mellitus. FDA approved uses: Byetta is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Available dosage forms: Solution for subcutaneous injection, prefilled multi-dose pen delivering doses of […]
NOVOLOG (insulin aspart recombinant) – an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. The primary activity of insulin, including insulin aspart, is regulation of glucose metabolism. Insulin and its analogs blood glucose by facilitating the cellular uptake of glucose and simultaneously inhibiting the output of glucose from the […]
LEVEMIR (insulin detemir recombinant) – a long acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. The primary activity of insulin, including insulin detemir, is regulation of glucose metabolism. Insulins, including insulin detemir, exert their specific action through binding to insulin receptors. Receptor-bound insulin lowers blood glucose by […]